PRKDC and metabolic dysfunction-associated steatotic liver disease: This process underscores DNA‐PK's involvement in the metabolic disturbances that characterize NAFLD, wherein excessive fat buildup in the liver leads to inflammation and, potentially, fibrosis (Figure 6B).